Why Do Americans Test Blood Sugar So Much More Than the Rest of the World?
Diabetes doesn’t look the same everywhere. In fact, the way Americans manage blood sugar — especially the constant testing, the fear of carbs, and the medication stacking — is almost unheard of in many other countries.
Across Europe and Asia, people with diabetes live calmer, steadier lives. They eat real meals. They walk daily. They don’t fear fruit. They don’t test six times a day. And they don’t take nearly as many medications.
So what’s going on? Why is the American experience so intense, expensive, and fear‑driven — while the rest of the world seems to live normally?
Let’s look at the lessons from around the world.
1. Testing: Americans Do It the Most — By Far
In the U.S., diabetics are often told to test:
- in the morning
- before meals
- after meals
- before bed
- “if you feel off”
In Europe and Asia, testing is occasional, not constant. This pattern is reflected in global comparisons from the International Diabetes Federation (IDF) Diabetes Atlas, which shows far lower daily testing frequency outside the U.S.
They test:
- when adjusting medication
- when sick
- when symptoms change
- occasionally to check patterns
That’s it.
Their meals are predictable. Their food is less processed. Their lifestyle includes daily movement. Their blood sugar is naturally more stable.
2. Test Strips: The Price Difference Is Wild
According to OECD Health Data and IDF Access to Medicines Reports, the cost gap is enormous.
United States: Test strips can cost fifty cents to a dollar fifty each. A box of 100 can run fifty to one hundred fifty dollars without insurance.
Europe: Often free. Or five to fifteen euros for a box of fifty to one hundred strips. National health systems cover most costs.
Asia: Five to twelve dollars for fifty strips. Or included in government health programs.
When testing is affordable and not fear‑driven, people don’t obsess over numbers.
3. Medications: Other Countries Use Fewer — and They Cost Less
The European Association for the Study of Diabetes (EASD) and the Japan Diabetes Society both emphasize lifestyle first, medication second — which is why fewer drugs are used overall.
United States: Medication is expensive and escalated quickly.
- Metformin: cheap
- DPP‑4 inhibitors (like Januvia): four hundred dollars or more
- SGLT2 inhibitors (like Jardiance): five hundred dollars or more
- GLP‑1s (Ozempic, etc.): nine hundred to twelve hundred dollars or more
- Insulin: one hundred to three hundred dollars per vial
Europe: Most diabetes meds are free or five to thirty euros per month. Insulin is heavily subsidized. GLP‑1s are used, but not pushed aggressively. Doctors don’t stack meds unless necessary.
Asia: Metformin: one to five dollars DPP‑4 inhibitors: twenty to forty SGLT2 inhibitors: twenty to fifty Insulin: five to twenty dollars per vial
Fewer meds because lifestyle is doing more of the work.
4. Carbs: The Fear Is American, Not Global
Global diet data from the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) consistently show that Europe and Asia consume high‑carbohydrate diets — bread, rice, noodles, potatoes, fruit — without higher diabetes complications when meals are structured and ultra‑processed foods are limited.
Europe and Asia eat carbs daily:
- bread
- rice
- noodles
- potatoes
- fruit
- beans
- lentils
And they do it without hesitation.
Their meals are:
- balanced
- predictable
- eaten at regular times
- paired with movement
- made from real ingredients
They don’t snack all day. They don’t eat ultra‑processed foods constantly. They don’t moralize carbs.
America is the outlier.
Here, people are taught:
- carbs are bad
- Only in America do people apologize for eating fruit. We’re the only country where people fear a banana
- fruit spikes you. Europe eats bread. We test after a grape.
- potatoes are dangerous
- measure out your berries like medication
This fear leads to:
- under‑eating
- rebound hunger
- spikes
- crashes
- panic
- more testing
- more meds
Other countries don’t live like this.
Globally, 7.6 billion people eat carbohydrate‑based diets, and many of them live with Type 2 diabetes. Yet they aren’t living in the same fear, panic, or complication‑driven culture we see in the U.S.
5. CGMs: America Uses Them the Most
The NHS (United Kingdom) and EASD reserve CGMs for Type 1 diabetes or complex Type 2 cases. In the U.S., CGMs are used for everything — including fear management.
United States: CGMs are used for reassurance, anxiety, micromanagement, diet confusion, and constant checking.
Europe: CGMs are used mainly for Type 1, insulin‑dependent Type 2, or complex cases. Doctors do not encourage CGMs for mild Type 2 or carb fear.
Asia: Similar to Europe — CGMs are used when medically necessary, not emotionally necessary.
CGMs amplify whatever culture they’re placed in.
In a calm food culture, CGMs are a tool. In a fear‑based food culture, CGMs become a panic button.
6. The Big Lesson: It’s Not the Diabetes — It’s the System
Americans test more because:
- the food is more processed
- the lifestyle is more sedentary
- the medical system is more fear‑based
- the costs are higher
- the messaging is more extreme
- the culture is more anxious
Other countries test less because:
- meals are structured
- food is real
- walking is normal
- doctors are calmer
- medication is affordable
- testing isn’t treated like a moral report card
This is the heart of the whole conversation:
Diabetes doesn’t have to be a full‑time job. It becomes one when the environment is chaotic.
Final Thought
If you’ve ever felt like diabetes in America is overwhelming, expensive, and fear‑driven, you’re not far off
Our system here is built on:
- fear
- ultra‑processed food
- sedentary living
- constant monitoring
- “don’t trust your body” messaging
Other countries don’t live this way.
And maybe we don’t have to either.
-Things to consider – Things that might free you from worry.
-Despina
Sources
World Health Organization — Global Diabetes Report International Diabetes Federation — Diabetes Atlas NHS (United Kingdom) — Type 2 Diabetes Management Guidelines European Association for the Study of Diabetes — Clinical Practice Recommendations Japan Diabetes Society — Treatment Guidelines OECD Health Data — Pharmaceutical Spending and Test Strip Costs FAO (Food and Agriculture Organization) — Global Food Consumption Patterns IDF Access to Medicines and Supplies Report